Salad Prices Are Soaring. An Unusual Culprit May Be To Blame
It’s not your imagination: that salad on your table is getting more expensive.
Apellis Pharmaceuticals Expects To Report About $65M Net Product Revenue From Sales Of EMPAVELI In The U.S For Year Ended Dec 31, 2022
On January 9, 2023, Apellis Pharmaceuticals, Inc. (the “Company”) posted on its website a corporate presentation, which it plans to present at the 41st Annual J.P. Morgan Health Care Conference on
Sage Therapeutics to Provide Update on 2023 Key Milestones at 41st Annual J.P. Morgan Healthcare Conference
Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Chief Executive Officer, Barry Greene, will discuss the Company's progress in developing a leading brain health pipeline at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.
‘You Can’t Ignore Us. Here We Are’ — Brock Pierce On Blockchain Hub Davos 2023
While the World Economic Forum (WEF) annual meeting begins in mid-January in Switzerland, the Web3 community will be represented in their parallel conference — Blockchain Hub Davos 2023.
AMD Unveils Suite Of New Radeon GPUs To Power High-Performance, Power-Efficient Gaming Laptops At CES 2023
Today at CES 2023, AMD (NASDAQ:AMD) announced the AMD Radeon™ RX 7000 Series Graphics for Laptops. Built on the groundbreaking AMD RDNA™ 3 architecture, the new GPUs are designed to deliver
Intercept Announces Efficacy And Safety Data From Phase 3 REGENERATE Study In Liver Fibrosis Fue To NASH To Be Presented At NASH-TAG Conference 2023 Jan 6-7
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced two abstracts on obeticholic acid (OCA) will be presented at the NASH-TAG Conference 2023.
Geron To Hold Conference Call For Top-Line Results From IMerge Phase 3 Clinical Trial On Jan. 4, 2023 At 8 a.m. EST
Geron Corporation (NASDAQ:GERN) today announced that it will host a conference call to discuss top-line results from the IMerge Phase 3 clinical trial of imetelstat, the Company's first-in-class telomerase inhibitor,
Tesla Announced It Will Hold its 2023 Investor Day on March 1
We plan to host Tesla's 2023 Investor Day on March 1, 2023. The event will be live streamed from our Gigafactory Texas, with the option for some of our institutional and retail investors to attend in person (details to follow).
Aridis Pharmaceuticals To Discuss Topline Data From Phase 3 Study Of AR-301 During Corporate Update Call On January 25
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, will host a conference